Pravastatin and the Development of Diabetes Mellitus : Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study

Circulation - United States
doi 10.1161/01.cir.103.3.357
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS)

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Treatment Goal Attainment for Secondary Prevention in Coronary Patients With or Without Diabetes Mellitus – Polish Multicenter Study POLASPIRE

Archives of Medical Science
Medicine
2020English

Novel Technologies for the Treatment and Prevention of Diabetes Mellitus and Its Complications

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Effect of Diabetes Mellitus on the Progression of the Severity of Coronary Arteriosclerosis

The Journal of Japan Atherosclerosis Society
1992English

Evidence for Inequalities in the Management of Coronary Heart Disease in Scotland

Heart
Cardiovascular MedicineCardiology
2005English

Respiratory Dysfunction in Patients With Sepsis: Protective Effect of Diabetes Mellitus

American Journal of Critical Care
MedicineCritical Care Nursing
2011English

The Treatment of Diabetes Mellitus

JAMA - Journal of the American Medical Association
Medicine
1936English

The Prevention of Type I Diabetes Mellitus

Pediatric Annals
Child HealthPediatricsPerinatology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy